Novavax Inc To Host Conference Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the call on the results from the pediatric expansion of the Novavax PREVENT-19 pivotal Phase III trial. (Operator Instructions) Please be advised that today's conference call is being recorded, but the recording will not be publicly distributed.
I would now like to turn the conference over to Silvia Taylor, Senior Vice President of Global Corporate Affairs. You may begin.
Good evening, everyone, and thank you to all of you who have joined today's call. We're delighted to share with you today the results from the adolescent portion of our PREVENT-19 pivotal Phase III trial. A press release announcing our results is currently available on our website at novavax.com, and an audio archive of this conference call will be available on our website later today. Please also note that we have posted the slides that we are us
ing during this evening's call at novavax.com/events.
Joining me today for discussion
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |